Search Results - "Vavassis, P."

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial by Brand, Douglas H, Tree, Alison C, Ostler, Peter, van der Voet, Hans, Loblaw, Andrew, Chu, William, Ford, Daniel, Tolan, Shaun, Jain, Suneil, Martin, Alexander, Staffurth, John, Camilleri, Philip, Kancherla, Kiran, Frew, John, Chan, Andrew, Dayes, Ian S, Henderson, Daniel, Brown, Stephanie, Cruickshank, Clare, Burnett, Stephanie, Duffton, Aileen, Griffin, Clare, Hinder, Victoria, Morrison, Kirsty, Naismith, Olivia, Hall, Emma, van As, Nicholas, Dodds, D, Lartigau, E, Patton, S, Thompson, A, Winkler, M, Wells, P, Lymberiou, T, Saunders, D, Vilarino-Varela, M, Vavassis, P, Tsakiridis, T, Carlson, R, Rodrigues, G, Tanguay, J, Iqbal, S, Morgan, S, Mihai, A, Li, A, Din, O, Panades, M, Wade, R, Rimmer, Y, Armstrong, J, Oommen, N

“…Localised prostate cancer is commonly treated with external-beam radiotherapy. Moderate hypofractionation has been shown to be non-inferior to conventional…”
Get full text

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial by Tree, Alison C, Ostler, Peter, van der Voet, Hans, Chu, William, Loblaw, Andrew, Ford, Daniel, Tolan, Shaun, Jain, Suneil, Martin, Alexander, Staffurth, John, Armstrong, John, Camilleri, Philip, Kancherla, Kiran, Frew, John, Chan, Andrew, Dayes, Ian S, Duffton, Aileen, Brand, Douglas H, Henderson, Daniel, Morrison, Kirsty, Brown, Stephanie, Pugh, Julia, Burnett, Stephanie, Mahmud, Muneeb, Hinder, Victoria, Naismith, Olivia, Hall, Emma, van As, Nicholas, Lartigau, E, Patton, S, Thompson, A, Winkler, M, Wells, P, Lymberiou, T, Saunders, D, Vilarino-Varela, M, Vavassis, P, Tsakiridis, T, Carlson, R, Rodrigues, G, Tanguay, J, Iqbal, S, Morgan, S, Mihai, A, Li, A, Din, O, Panades, M, Wade, R, Rimmer, Y, Oommen, N

“…Localised prostate cancer is commonly treated with external beam radiotherapy and moderate hypofractionation is non-inferior to longer schedules. Stereotactic…”
Get full text

Tumour Response 3 Months after Neoadjuvant Single-Fraction Radiotherapy for Low-Risk Breast Cancer by Tiberi, D., Vavassis, P., Nguyen, D., Guilbert, M.C., Simon-Cloutier, A., Dubé, P., Gervais, M.K., Sideris, L., Leblanc, G., Hijal, T., Dufresne, M.P., Yassa, M.

“…Introduction: Standard treatment for early-stage invasive breast cancer (bca) consists of breast-conserving surgery and several weeks of adjuvant radiotherapy…”
Get full text

Complication Rates in Fiducial Marker Implantation for Prostate Radiation Therapy by Fawaz, Z.S, Yassa, M, Nguyen, D.H, Vavassis, P

Get full text

Fiducial marker implantation in prostate radiation therapy: Complication rates and technique by Fawaz, Z.S., Yassa, M., Nguyen, D.H., Vavassis, P.

“…This study aims to report the complication rate from the transrectal ultrasound-guided implantation of gold seed markers in prostate radiotherapy, as well as…”
Get full text

Regional Nodal Radiation Therapy in Breast Cancer Patients With Positive Nodes Who Convert to Negative Nodes After Neoadjuvant Chemotherapy by Yassa, M, Fawaz, Z, Nguyen, D, Fortin, B, Sideris, L, Vavassis, P

Get full text

Late Consequential Effects of Hypofractionated Radiation Therapy in Prostate Cancer: Impact of Acute Toxicity on Toxicity at 4 Years and 8 Years by Yassa, M, Vavassis, P, Fortin, B, Fortin, M, Lambert, C, Nguyen, T, Bahary, J

Get full text

479 Does the Effect of Clip Displacement On Target Volume Potentially Hamper the Concept of Partial Breast Irradiation in Prone Position? by Vanderick, J, Lakosi, F, Janvary, L, Seidel, L, Vavassis, P, Coucke, P

Get full text

Guideline for testosterone recovery in localized prostate cancer treated with different ADT duration: Long-term data from two prospective randomized trials by Nabid, A., Carrier, N., Martin, A-G., Bahoric, B., Wilke, D., Vigneault, E., Vincent, F., Bahary, J-P., Brassard, M-A., Duclos, M., Vavassis, P., Bettahar, R., Archambault, R., Vass, S., Nguyen, T.V., Souhami, L.

Get full text

Variability of Whole Breast Target Volume Delineation Between Prone and Supine Position: A Multicentric Study by Lakosi, F, Janvary, L, Vanderick, J, Lombard, N, Meyns, M, Seidel, L, Vavassis, P, Untereiner, M, Coucke, P

Get full text

EP-1300: Introduction of SagittiltÆ prone breast board into daily practice: From pre-clinical to first clinical experiences by Lakosi, F, Lallemand, F, Janvary, L, Mievis, C, Mathot, M, Wonner, M, Gulyban, A, Coucke, P, Seidel, L, Vavassis, P

Get full text

110 COMPARISON OF RESPIRATION-RELATED SURGICAL CLIP AND CHEST WALL MOVEMENT BETWEEN PRONE AND SUPINE POSITION IN THE ADJUVANT RADIOTHERAPY OF BREAST CANCER by Lakosi, F, Janvary, L, Beelen, Z, Vavassis, P, Seidel, L, Coucke, P

Get full text

Quality of Life and Weight Variation during Androgen Deprivation Therapy in Patients with High-Risk Prostate Cancer: Long-Term Data from a Phase III Trial by Nabid, A., Carrier, N., Martin, A.G., Bahary, J.P., Vavassis, P., Vass, S.T., Bahoric, B., Archambault, R., Vincent, F., Bettahar, R., Duclos, M., Souhami, L.

“…We assessed the impact of weight (wt) variation on quality of life (QoL). Using data from a Phase III trial in high-risk prostate cancer (HRPC) and based on…”
Get full text

Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy by Nabid, A., Carrier, N., Martin, A.G., Bahary, J.P., Vavassis, P., Vass, S.T., Bahoric, B., Archambault, R., Vincent, F., Bettahar, R., Souhami, L.

“…In a previous report from a randomized trial of 630 patients (pts), we showed that 18 months of androgen deprivation therapy (18m ADT) appears to be equally…”
Get full text

Biochemical Failure in Intermediate Risk Prostate Cancer: Then What? Long-Term Data from a Phase III Trial by Nabid, A., Carrier, N., Vigneault, E., Nguyen, T.V., Vavassis, P., Brassard, M.A., Bahoric, B., Archambault, R., Vincent, F., Bettahar, R., Wilke, D.R., Souhami, L.

“…Aiming to determine long-term outcomes post biochemical failure (BF) in patients (pts) treated for intermediate-risk prostate cancer, we analyzed data from our…”
Get full text

Biochemical Recurrence is Not a Surrogate for Overall Survival in Localized Prostate Cancer: Data from 2 Phase III Trials by Nabid, A., Carrier, N., Vigneault, E., Martin, A.G., Nguyen, T.V., Bahary, J.P., Vavassis, P., Bahoric, B., Brassard, M.A., Vass, S.T., Archambault, R., Vincent, F., Bettahar, R., Duclos, M., Wilke, D.R., Souhami, L.

“…Aiming to confirm that biochemical recurrence (BR) is not a surrogate for overall survival (OS) in patients (pts) treated for intermediate risk prostate cancer…”
Get full text

PO-1544 Outcomes comparison using PSA cut-off values of 0.1 at 6 months in high-risk prostate cancer by Nabid, A., Carrier, N., Martin, A., Bahary, J., Vavassis, P., Bahoric, B., Archambault, R., Vincent, F., Bettahar, R., Duclos, M., Souhami, L.

Get full text

Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials by Nabid, A., Carrier, N., Martin, A-G., Vigneault, E., Nguyen, T-V., Bahary, J.P., Vavassis, P., Bahoric, B., Brassard, M.A., Vass, S., Archambault, R., Vincent, F., Bettahar, R., Duclos, M., Wilke, D., Souhami, L.

Get full text

A0601 - Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials by Nabid, A., Carrier, N., Martin, A-G., Vigneault, E., Nguyen, T-V., Bahary, J.P., Vavassis, P., Bahoric, B., Brassard, M.A., Vass, S., Archambault, R., Vincent, F., Bettahar, R., Duclos, M., Wilke, D., Souhami, L.

Get full text

Cardiovascular Causes of Death in Patients Treated for Localized Prostate Cancer by Nabid, A., Carrier, N., Vigneault, E., Brassard, M.A., Bahoric, B., Archambault, R., Vavassis, P., Vincent, F., Bettahar, R., Wilke, D.R., Nguyen, T.V., Martin, A.G., Bahary, J.P., Duclos, M., Vass, S.T., Souhami, L.

Get full text